Extract
Cortex Announces Update on CX717 Clinical Hold.
IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR) announced that it has provided to the U.S. Food and Drug Administration the preclinical research p...
See the full content of this document
Sponsored links
